Effects of nonoxynol-9 on vaginal microflora and chlamydial infection in a monkey model

Sexually Transmitted Diseases

Volumn 23, Issue 6, 1996, Pages 461-464

  Patton, Dorothy L ^a   Kidder, Gretchen Ganzle ^a   Sweeney, Yvonne Cosgrove ^a   Rabe, Lorna K ^c   Clark, Agnes M ^b   Hillier, Sharon L ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9;

ANAEROBIC BACTERIUM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; ERYTHEMA; FEMALE; INTRAVAGINAL DRUG ADMINISTRATION; LACTOBACILLUS; MONKEY; NONHUMAN; PEPTOSTREPTOCOCCUS; UTERINE CERVICITIS; VAGINA FLORA;

EID: 0029822006     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199611000-00004     Document Type: Article

References (20)

1. Louv WC, Austin H, Alexander WJ, Stagno S, Creeks S. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-523.
2. Rosenberg MJ, Rojanapithayakorn W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. JAMA 1987; 257:2308-2312.
3. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
4. Weir SS, Feldblum PJ, Zekeng L, Roddy RE. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994; 84:910-914.
5. Knight ST, Lee SH, Davis CH, Moorman DR, Hodinka RL, Wyrick PB. In vitro activity of nonoxynol-9 on McCoy cells infected with Chlamydia trachomatis. Sex Transm Dis 1987; 14:165-173.
6. Patton DL, Wang S, Kuo CC. In vitro activity of nonoxynol-9 on HeLa 229 and primary monkey cervical epithelial cells in-fected with Chlamydia trtichomatis. Antimicrob Agents Chemother 1992; 36:1478-1482.
7. Bolch OH, Warren JC. In vivo effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis. Am J Obstet Gynecol 1973; 115:1145-1148.
8. Singh B, Cutler JC, Utidjian HMD. Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception: II: In vitro effect of contraceptive and noncontraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis 1972; 48:57-64.
9. Kappus EW, Quinn TC. The spermicide nonoxynol-9 does not inhibit C. trachomatis in vitro. Sex Transm Dis 1986; 13:134-137.
10. Niruthisard S, Roddy RE, Chutivongse S.Use of nonoynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-1375.
11. Patton DL, Cosgrove Sweeney Y, Rabe LK, Hillier SL. The vaginal microflora of pigtailed macaques and the effects of chlorhexidine and benzalkonium on this ecosystem. Sex Transm Dis 1996; 23:489-493.
12. Baron EJ, Strong CA, McTeague M, Vaisanen M-L, Finegold SM. Survival of anaerobes in original specimens transported by overnight mail services. Clin Infect Dis 1995; 20(suppl 2):5174-5177.
13. Stamm WE, Tam M, Koester M, Cles L. Detection of Chiamydia trachomatis inclusions in McCoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol 1983; 17:666-668.
14. Dille BJ, Butzen CC, Birkenmeyer LG. Amplification of Chlamydia trachomatis DNA by ligase chain reaction. J Clin Microbiol 1993; 31:729-731.
15. Tam MR, Stamm WE, Handsfield HH, et al. Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med 1984; 310:1146-1150.
16. Wang S-P, Grayston JT, Alexander ER, Holmes KK. Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chiamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol 1975; 1:250-255.
17. Wang S-P, Grayston JT. Local and systemic antibody response to trachoma eye infection in monkeys. In: Nichols RL, ed. Trachoma and related disorders caused by chlamydial agents. Amsterdam: Excerpta Medica. 1971; 217-232.
18. Lyons JM, Ito JI Jr. Reducing the risk of Chlamydia trachomatis genital tract infection by evaluating the prophylactic potential of vaginally applied chemicals. Clin Infect Dis 1995; 21(suppl):S174-S177.
19. Niruthisard S, Roddy RE, Chutivongse S. The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sex Transm Dis 1991; 18:176-179.
20. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4:165-170.